6-Hydroxypurine

CAS No. 68-94-0

6-Hydroxypurine( 6-Hydroxypurine | NSC 14665 | NSC 129419 )

Catalog No. M15636 CAS No. 68-94-0

A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 45 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6-Hydroxypurine
  • Note
    Research use only, not for human use.
  • Brief Description
    A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
  • Description
    A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    6-Hydroxypurine | NSC 14665 | NSC 129419
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Purine nucleoside phosphorylase
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    68-94-0
  • Formula Weight
    136.11
  • Molecular Formula
    C5H4N4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 0.4 mg/mL (2.93 mM)
  • SMILES
    O=C1NC=NC2=C1N=CN2
  • Chemical Name
    1,9-dihydro-6H-purin-6-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Overington JP, et al. Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
molnova catalog
related products
  • Rusalatide acetate

    Rusalatide acetate (TP508 amide acetate), a regenerated peptide, alleviates radiation-induced gastrointestinal injury by activating stem cells and protecting recess integrity.

  • Amino-PEG10-acid

    Amino-PEG10-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • Brilliant Blue FCF

    Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury.